163 related articles for article (PubMed ID: 8024753)
1. Potential use of poliovirus as a vector.
Girard M; Martin A; van der Werf S
Biologicals; 1993 Dec; 21(4):371-7. PubMed ID: 8024753
[TBL] [Abstract][Full Text] [Related]
2. Development of candidates for new type 2 and type 3 oral poliovirus vaccines.
Kohara M; Abe S; Yoshioka I; Nomoto A
Dev Biol Stand; 1993; 78():141-8. PubMed ID: 8388824
[TBL] [Abstract][Full Text] [Related]
3. Attenuated poliovirus strain as a live vector: expression of regions of rotavirus outer capsid protein VP7 by using recombinant Sabin 3 viruses.
Mattion NM; Reilly PA; DiMichele SJ; Crowley JC; Weeks-Levy C
J Virol; 1994 Jun; 68(6):3925-33. PubMed ID: 8189529
[TBL] [Abstract][Full Text] [Related]
4. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
[TBL] [Abstract][Full Text] [Related]
5. A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain.
Kohara M; Abe S; Komatsu T; Tago K; Arita M; Nomoto A
J Virol; 1988 Aug; 62(8):2828-35. PubMed ID: 2839704
[TBL] [Abstract][Full Text] [Related]
6. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype.
Rezapkin GV; Fan L; Asher DM; Fibi MR; Dragunsky EM; Chumakov KM
Virology; 1999 May; 258(1):152-60. PubMed ID: 10329577
[TBL] [Abstract][Full Text] [Related]
7. Dicistronic polioviruses as expression vectors for foreign genes.
Alexander L; Lu HH; Gromeier M; Wimmer E
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S57-60. PubMed ID: 7865334
[TBL] [Abstract][Full Text] [Related]
8. Characterization of poliovirus replicons encoding carcinoembryonic antigen.
Ansardi DC; Moldoveanu Z; Porter DC; Walker DE; Conry RM; LoBuglio AF; McPherson S; Morrow CD
Cancer Res; 1994 Dec; 54(24):6359-64. PubMed ID: 7527296
[TBL] [Abstract][Full Text] [Related]
9. Evolution and polymorphism of poliovirus genomes.
Crainic R; Kew O
Biologicals; 1993 Dec; 21(4):379-84. PubMed ID: 8024754
[TBL] [Abstract][Full Text] [Related]
10. Canyon rim residues, including antigenic determinants, modulate serotype-specific binding of polioviruses to mutants of the poliovirus receptor.
Harber J; Bernhardt G; Lu HH; Sgro JY; Wimmer E
Virology; 1995 Dec; 214(2):559-70. PubMed ID: 8553558
[TBL] [Abstract][Full Text] [Related]
11. [Mouse neurovirulence of antigenic chimeras (type I/II) of polioviruses].
Dai C
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Feb; 15(1):34-8. PubMed ID: 7686824
[TBL] [Abstract][Full Text] [Related]
12. Antigen chimaeras of poliovirus as potential new vaccines.
Burke KL; Dunn G; Ferguson M; Minor PD; Almond JW
Nature; 1988 Mar; 332(6159):81-2. PubMed ID: 2450279
[TBL] [Abstract][Full Text] [Related]
13. Poliovirus type 3/Saukett: antigenic and structural correlates of sequence variation in the capsid proteins.
Huovilainen A; Kinnunen L; Pöyry T; Laaksonen L; Roivainen M; Hovi T
Virology; 1994 Feb; 199(1):228-32. PubMed ID: 8116248
[TBL] [Abstract][Full Text] [Related]
14. Formation of poliovirus-like particles by recombinant baculoviruses expressing the individual VP0, VP3, and VP1 proteins by comparison to particles derived from the expressed poliovirus polyprotein.
Bräutigam S; Snezhkov E; Bishop DH
Virology; 1993 Feb; 192(2):512-24. PubMed ID: 8380663
[TBL] [Abstract][Full Text] [Related]
15. Genetic basis of attenuation of the Sabin oral poliovirus vaccines.
Minor PD; Macadam AJ; Stone DM; Almond JW
Biologicals; 1993 Dec; 21(4):357-63. PubMed ID: 8024751
[No Abstract] [Full Text] [Related]
16. Cell clones cured of persistent poliovirus infection display selective permissivity to the wild-type poliovirus strain Mahoney and partial resistance to the attenuated Sabin 1 strain and Mahoney mutants.
Calvez V; Pelletier I; Couderc T; Pavio-Guédo N; Blondel B; Colbère-Garapin F
Virology; 1995 Oct; 212(2):309-22. PubMed ID: 7571400
[TBL] [Abstract][Full Text] [Related]
17. Immune responses induced by administration of encapsidated poliovirus replicons which express HIV-1 gag and envelope proteins.
Moldoveanu Z; Porter DC; Lu A; McPherson S; Morrow CD
Vaccine; 1995 Aug; 13(11):1013-22. PubMed ID: 8525684
[TBL] [Abstract][Full Text] [Related]
18. Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates.
Macadam AJ; Pollard SR; Ferguson G; Skuce R; Wood D; Almond JW; Minor PD
Virology; 1993 Jan; 192(1):18-26. PubMed ID: 8390752
[TBL] [Abstract][Full Text] [Related]
19. Poliovirus attenuation and pathogenesis in a transgenic mouse model for poliomyelitis.
Racaniello VR; Ren R; Bouchard M
Dev Biol Stand; 1993; 78():109-16. PubMed ID: 8388820
[TBL] [Abstract][Full Text] [Related]
20. Targeted foreign gene expression in spinal cord neurons using poliovirus replicons.
Bledsoe AW; Gillespie GY; Morrow CD
J Neurovirol; 2000 Apr; 6(2):95-105. PubMed ID: 10822323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]